Beryl Drugs

Beryl Drugs Inventory

The Inventory of Beryl Drugs (524606.BO) as of Nov 1, 2026 is 31.27 M INR. In the previous year, Inventory was 19.03 M INR — a change of 64.32% (higher).

Inventory

31.27 MINR

YoY

64.32%

Last updated:

Inventory of Beryl Drugs is 2026 31.27 M INR. Inventory of Beryl Drugs was 2025 19.03 M INR. It decreases by 64.32% higher compared to the previous year.

The Beryl Drugs Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2019
7.64 M INR
Jan 1, 2020
11.57 M INR
Jan 1, 2021
22.69 M INR
Jan 1, 2022
29.78 M INR
Jan 1, 2023
10.55 M INR
Jan 1, 2024
12.60 M INR
Jan 1, 2025
19.03 M INR
Jan 1, 2026
31.27 M INR
The Beryl Drugs Inventory history
YEARInventoryYoY
31.27 MINR+64.32%
19.03 MINR+50.99%
12.60 MINR+19.48%
10.55 MINR-64.59%
29.78 MINR+31.26%
22.69 MINR+96.05%
11.57 MINR+51.52%
7.64 MINR-43.31%
13.47 MINR-49.91%
26.90 MINR+74.41%
15.42 MINR+2.63%
15.03 MINR+6.86%
14.06 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Beryl Drugs Stock analysis

What does Beryl Drugs do? Beryl Drugs Ltd. manufactures bulk drugs and offers small volume injectables in liquid and dry powder forms, eye and ear drops, intravenous fluids in poly packs and glass bottles, and veterinary medicines. The company supplies domestically, institutionally, and for export, leveraging its Pithampur manufacturing facility. It markets branded and generic pharmaceutical formulations through its nationwide sales and distribution network. The firm's revenue streams come from the sale of bulk drugs to pharmaceutical manufacturers and the distribution of branded and generic formulations to domestic and international markets. Institutional buyers include hospitals and healthcare providers, while export markets receive bulk drug supplies and veterinary medicines. Domestic sales focus on retail pharmacies and healthcare institutions. Beryl Drugs Ltd. serves the pharmaceutical industry by providing bulk drug manufacturing services and branded generic formulations. Its products are distributed through a nationwide network, targeting both institutional and retail segments. The company's export segment includes veterinary medicines and bulk drug supplies to international clients. Beryl Drugs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beryl Drugs stock

Inventory of Beryl Drugs is 31.27 M INR in 2026.

Inventory of Beryl Drugs changed from 19.03 M INR to 31.27 M INR, representing a 64.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Beryl Drugs since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Beryl Drugs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Beryl Drugs

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Beryl Drugs